Key Concepts of Clinical Trials
The renewed focus on comparative effectiveness research by the federal government serves
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
The renewed focus on comparative effectiveness research by the federal government serves
various preclinical models of COPD. Its clinical development was based mainly on Phase III studies initially performed in COPD patients with various stages of disease severity and then focused ... function. This article…
approaches towards treating locally advanced pancreatic cancer. The LAP-07 study, a large phase III study with two separate randomizations, updated their accrual status, but with no interim data ... tolerability of…
Diabetes prevention programs have been implemented in our country’s health institutions
Diabetes Prevention Programs have been implemented in our country's health institutions
Jersey) through non-clinical in vitro study in healthy volunteers and clinical studies (phases III and IV) in patients with acute coronary syndrome (ACS). For non-clinical study, blood from ... parameters of TGT were…
daily regimen was chosen for all the studied indications of apixaban. All three Phase III studies in the prevention of venous thromboembolism after total hip or knee replacement (ADVANCE
setting closer to clinical practice than that typically described in Phase III studies have recently been revealed by some Phase IIIb studies (the TAMARA, ROSE, ACT‑SURE
Trastuzumab-Pertuzumab-Docetaxel association. Study TOC4129g (WO20698), initiated in 2008 is a randomized Phase III study (CLEOPATRA) for the first-line treatment of HER2-positive MBC. The median
cell NHL patients with Iranian ethnicity. In phase Ð?Ð?Ð? trail, patients with previously untreated stage III and IV indolent and aggressive B-cell NHL were randomly assigned ... hundred and forty three patients were…
PI3K inhibitor buparlisib (BKM120) and the PI3Kα-specific inhibitor alpelisib (BYL719). Early clinical studies with these compounds indicated the safety profiles were manageable, with mostly on-target adverse events…
placebo-controlled study with annualized relapse rates as the principal clinical outcome in Phase III studies. As therapies have been developed, problems have arisen with changing trial populations with lower
introduced in the drug development process to analyze PK/PD data from pivotal Phase III studies. This movement to the regulated pharmaceutical industry resulted in much needed improvement and order ... models are…
international approval for the treatment of bone metastases and bone lesions from cancer. Phase III studies established the efficacy and safety profile of zoledronic acid in a broad range ... study with pamidronate…
studies, fevipiprant showed a favorable safety profile. LUSTER-1 and -2 are replicate Phase III studies whose aim is to determine the efficacy, safety and tolerability of fevipiprant
four of the phase II trials were less than a ½ SD. For phase III studies, the effect sizes for all but one study were below 0.4 SD and roughly ... trials did have slightly larger effect sizes. Conclusions: Even highly…
phase III study (CONSOLE study). Although the exploratory analysis of the CONSOLE study suggested the effectiveness of triplet antiemetic therapy, including FosNTP, in the extended overall phase
American Society of Clinical Oncology (ASCO) Gastrointestinal Cancer Symposium, the randomized phase III study presented by Uesaka et al. from Japan (Abstract #145) represents a newer paradigm of oral adjuvant
efficacy of this compound in men with mCRPC. Interim results from a randomized Phase III study in CRPC patients previously treated with docetaxel demonstrated an improvement in overall survival
pyrimidine-based multitargeted antifolate agent, has shown significant activity, and in the only Phase III study comparing two chemotherapy regimes (the EMPHACIS study), it has been demonstrated that the combination
young women following QHPV vaccination. Review of safety trials finds phase III studies excluded the vaccine’s target group; vaccination of placebo cohorts precluded long term safety observation; post marketing
maintaining glycemic control, while restoring insulin secretion in Japanese patients. In the Japanese Phase III studies, liraglutide demonstrated significant reductions in glycated hemoglobin (HbA1c) levels and body…
experienced genotype 1 patients. This article reviews the results of the recently reported Phase III studies: ADVANCE, ILLUMINATE and REALIZE, which reported sustained virological response as high
considered as a potential topical medication for preventing radiation-induced oral mucositis. Phase III study with larger number of patients and comparing with market product will be made for confirmation
phase Ⅲ vaccine trial is a field evaluation. It is of important value to study the current evaluation indicators of vaccine protection effect and the existing eligibility criteria for testing ... health measures. We…
For authors and organisers
Find the right journal for your paper and submit your manuscript.